Keyphrases
Type I Diabetes
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Hypoglycemia
91%
Hyperglycemia
44%
Euglycaemia
42%
A1 Receptor
36%
Glucagon-like
36%
Receptor Agonist
36%
Ventricular Arrhythmia
26%
Glycaemia
25%
Type 2 Diabetes Prevention
24%
Type 2 Diabetes Mellitus (T2DM)
23%
Recovery Phase
21%
Incretin
20%
Male Person
20%
Obesity Treatment
20%
Hemostatic Effect
20%
Exercise Effect
20%
Non-alcoholic Fatty Liver Disease (NAFLD)
20%
Prospective Observational Study
20%
Rebound Hyperglycemia
20%
Arrhythmia
20%
Corrected QT Prolongation
20%
Patient Selection
20%
Left Ventricular Systolic Function
20%
QT Prolongation
20%
GLP-1 Receptor Agonist
20%
Clinical Patients
20%
Agonist Treatment
20%
Everyday Clinical Practice
20%
Heart Rate
20%
Plasma Glucose
17%
Euglycemic
16%
Tp-e Interval
13%
Global Longitudinal Strain
12%
Cardiovascular Disease
11%
Hyperinsulinemic
11%
Randomized Crossover Study
10%
Glycemic Variability
10%
Asymptomatic Hypoglycemia
10%
QTc Interval
10%
Cardiac Repolarization
10%
Clot
8%
Incident Rate Ratio
8%
Hypo
8%
Nighttime
8%
LV Ejection Fraction
8%
Steady State
6%
State Phase
6%
Improved Outcomes
6%
Medicine and Dentistry
Hypoglycemia
93%
Insulin Dependent Diabetes Mellitus
82%
Hyperglycemia
51%
Glucagon-Like Peptide-1 Agonist
30%
Maturity Onset Diabetes of the Young
30%
Arrhythmia
23%
Antidiabetic Agent
21%
Incretin
20%
Translating (Language)
20%
Observational Study
20%
QT Prolongation
20%
Hemostat
20%
QTc Interval
20%
Patient Selection
20%
Nonalcoholic Fatty Liver
20%
Patient with Type 1 Diabetes
20%
Cardiac Dysrhythmia
20%
Systolic Function
20%
Rebound
20%
Disease
10%
Heart Repolarization
10%
Glycemic
9%
Body Weight
7%
Steady State
6%
Fibrinolysis
6%
Heart Rate Variability
6%
Ejection Fraction
5%
Cardiovascular Disease
5%
Target Organ
5%
Gastric Inhibitory Polypeptide
5%
Hemoglobin A1c
5%
Receptor
5%
Water-Electrolyte Imbalance
5%
Tirzepatide
5%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon Like Peptide 1 Receptor Agonist
50%
Non Insulin Dependent Diabetes Mellitus
47%
Insulin Dependent Diabetes Mellitus
40%
Hypoglycemia
34%
Hyperglycemia
30%
Heart Arrhythmia
23%
Nonalcoholic Fatty Liver
22%
QT Prolongation
20%
Incretin
20%
Observational Study
20%
Disease
12%
Antidiabetic Agent
6%
Metabolic Disorder
5%
Gastric Inhibitory Polypeptide Receptor
5%
Cardiovascular Disease
5%
Tirzepatide
5%
Hemoglobin A1c
5%
